Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Q3 2024 vs. Q2 2024
How the institutions holding Wave Life Sciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 144 | 2 | 162 | +20 |
| Shares | 95.1M | 6.76M | 120.2M | +31.9M (+36.2%) |
| Value | $474.4M | $33.7M | $986.1M | +$545.4M (+123.8%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Wave Life Sciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (17)
Institutions that held Wave Life Sciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 4,566,251 | $22.8M |
| Laurion Capital Management LP | 516,473 | $2.58M |
| Exome Asset Management LLC | 488,135 | $2.44M |
| Avidity Partners Management LP | 350,000 | $1.75M |
| Ghost Tree Capital, LLC | 200,000 | $998.0K |
| Prelude Capital Management, LLC | 135,200 | $674.6K |
| Schonfeld Strategic Advisors LLC | 102,635 | $512.1K |
| Susquehanna International Group, LLP | 78,048 | $389.5K |
| ADAR1 Capital Management, LLC | 76,651 | $382.5K |
| Two Sigma Advisers, LP | 28,700 | $143.2K |
| Ameriprise Financial Inc | 25,994 | $129.7K |
| Verition Fund Management LLC | 25,917 | $129.3K |
| Omers Administration Corp | 14,900 | $74.4K |
| Principal Financial Group Inc | 14,766 | $73.7K |
| Public Employees Retirement System of Ohio | 11,390 | $56.8K |
| Aspire Private Capital, LLC | 150 | $749 |
| Allworth Financial LP | 3 | $18 |
Not filed for Q3 2024 yet (2)
Institutions that held Wave Life Sciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 6,738,735 | $33.6M |
| Susquehanna Fundamental Investments, LLC | 18,744 | $93.5K |